These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 325145)
1. Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes. Haynes BF; Fauci AS J Immunol; 1977 Jun; 118(6):2281-7. PubMed ID: 325145 [TBL] [Abstract][Full Text] [Related]
2. Activation of human B lymphocytes. V. Kinetics and mechanisms of suppression of plaque-forming cell responses by concanavalin A-generated suppressor cells. Haynes BF; Fauci AS J Immunol; 1978 Mar; 120(3):700-8. PubMed ID: 147296 [TBL] [Abstract][Full Text] [Related]
3. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF). Pisko EJ; Foster SL; White RE; Panetti M; Turner RA J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423 [TBL] [Abstract][Full Text] [Related]
4. Activation of human B lymphocytes. II. Cellular interactions in the PFC response of human tonsillar and peripheral blood B lymphocytes to polyclonal activation by pokeweed mitogen. Fauci AS; Pratt KR; Whalen G J Immunol; 1976 Dec; 117(6):2100-4. PubMed ID: 792339 [TBL] [Abstract][Full Text] [Related]
5. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response. Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay. Jones BM Clin Exp Immunol; 1981 Oct; 46(1):196-205. PubMed ID: 6461453 [TBL] [Abstract][Full Text] [Related]
7. Induction or suppression of B cell proliferation and differentiation by phytohemagglutinin or concanavalin A in mouse spleen cell cultures. Piguet PF; Dewey HK; Vassalli P J Immunol; 1976 Nov; 117(5 Pt.2):1817-23. PubMed ID: 1086865 [TBL] [Abstract][Full Text] [Related]
8. Suppressor lymphocytes in young and aged humans. Hallgren HM; Yunis EJ J Immunol; 1977 Jun; 118(6):2004-8. PubMed ID: 864254 [TBL] [Abstract][Full Text] [Related]
9. Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation. Fauci AS; Pratt KR; Whalen G J Immunol; 1977 Aug; 119(2):598-603. PubMed ID: 328777 [TBL] [Abstract][Full Text] [Related]
10. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies. Jones BM Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the primary in vitro antibody response in human peripheral blood lymphocytes: different effects of mitogen-induced and spontaneous T suppressor cells. Galanaud P; Crevon MC; Delfraissy JF; Segond P; Wallon C; Dormont J Clin Exp Immunol; 1979 Oct; 38(1):106-15. PubMed ID: 316750 [TBL] [Abstract][Full Text] [Related]
12. Triggering of human peripheral blood B cells: polyclonal induction and modulation of an in vitro PFC response. Friedman SM; Breard JM; Chess L J Immunol; 1976 Nov; 117(5 Pt.2):2021-8. PubMed ID: 792335 [TBL] [Abstract][Full Text] [Related]
13. Activation of human B lymphocytes. X. Heterogeneity of concanavalin A-generated suppressor cells of the pokeweed mitogen-induced plaque-forming cell response of human peripheral blood lymphocytes. Haynes BF; Fauci AS J Immunol; 1978 Aug; 121(2):559-65. PubMed ID: 355547 [No Abstract] [Full Text] [Related]
14. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis. Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ J Immunol; 1977 Mar; 118(3):952-6. PubMed ID: 15032 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the polyclonal B-cell response to lipopolysaccharide by concanavalin-A-treated non-T cells in vitro. Matsumoto T; Nakano M; Shibata M Immunology; 1982 Dec; 47(4):651-61. PubMed ID: 6216201 [TBL] [Abstract][Full Text] [Related]
16. T-dependent activation of resting B cells mediated by concanavalin A. Ratcliffe MJ; Julius MH Eur J Immunol; 1984 Mar; 14(3):280-3. PubMed ID: 6231188 [TBL] [Abstract][Full Text] [Related]
17. The effect of staphylococcal enterotoxins on the primary in vitro immune response. Smith BG; Johnson HM J Immunol; 1975 Aug; 115(2):575-8. PubMed ID: 1097520 [TBL] [Abstract][Full Text] [Related]
18. Polyclonal activation of human lymphocytes in vitro-II. Reappraisal of T and B cell-specific mitogens. Dosch HM; Schuurman RK; Gelfand EW J Immunol; 1980 Aug; 125(2):827-32. PubMed ID: 6993564 [TBL] [Abstract][Full Text] [Related]
19. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation. Stevenson HC; Fauci AS Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766 [TBL] [Abstract][Full Text] [Related]
20. Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses. Sakane T; Green I J Immunol; 1977 Sep; 119(3):1169-78. PubMed ID: 302273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]